Chemotherapy of pancreatic cancer
Smith, F.P.; Schein, P.S.
Seminars in Oncology 6(3): 368-377
1979
ISSN/ISBN: 0093-7754 PMID: 388637 Document Number: 149210
Document emailed within 1 workday
Related Documents
Ozaki, H.; Ishii, K. 1972: Systemic chemotherapy of pancreatic cancer Gan no Rinsho. Japan Journal of Cancer Clinics 1972(Suppl): 382-384Berlin, J.D.; Rothenberg, M. 2001: Chemotherapy for resectable and advanced pancreatic cancer Oncology 15(10): 1241-1249; 1254; Discussion: 1254-1264
Sunagozaka, H.; Yamashita, T.; Kagaya, T.; Kato, Y.; Kaneko, S. 2006: A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(6): 829-832
Ueno, H.; Okusaka, T. 2012: Systemic chemotherapy and chemoradiotherapy for advanced pancreatic cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(3): 357-363
Hayashi, K.; Uchida, K.; Hatori, T.; Takasaki, K. 2006: TS-1: S-1 based chemotherapy for far-advanced or relapsed pancreatic cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 1): 194-197
Siu, T.O.; Kwan, W.B. 1989: Hormones in chemotherapy for pancreatic cancer, chemoagents or carriers? In Vivo 3(4): 255-258
Ohkawa, S. 2006: Gemcitabine chemotherapy for patients with advanced or relapsed pancreatic cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 1): 198-202
Egawa, T.; Ohashi, M.; Ito, Y.; Mihara, K.; Takahashi, T.; Hayashi, S.; Nagashima, A. 2009: A partial response to S-1 as second-line chemotherapy in a patient with unresectable pancreatic cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 2422-2424
Takiuchi, D.; Morimoto, O.; Eguchi, S.; Hokkoku, D.; Wada, R.; Ikeshima, R.; Munakata, K.; Wada, N.; Okura, E.; Azama, T.; Akamaru, Y.; Ota, H.; Kitada, M.; Shibata, K.; Ohashi, H. 2019: A Case of Chemotherapy with Abscess Drainage for Pancreatic Cancer Detected Due to Peritonitis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(13): 2458-2460
Ishikawa, O.; Ohigashi, H.; Imaoka, S.; Sasaki, Y.; Kameyama, M.; Nakamori, S.; Kabuto, T.; Furukawa, H. 1997: Regional chemotherapy to prevent hepatic metastasis after resection of pancreatic cancer Hepato-Gastroenterology 44(18): 1541-1546
Takahata, T.; Sato, A.; Yu, C.; Saito, K. 2018: Retrospective Analysis of Weekly Paclitaxel Chemotherapy for Gemcitabine- and S-1-Resistant Pancreatic Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(5): 817-821
Ohara, T.; Fujino, Y.; Goto, H.; Yamashita, H.; Oyama, M.; Katsura, M.; Sugiyama, H.; Ueda, Y.; Hasegawa, H.; Yasuda, T.; Kakinoki, K.; Oshikiri, T.; Sendo, H.; Sugimoto, T.; Tominaga, M. 2015: A case of stage IV b pancreatic head cancer that was resected because of a good response to chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(5): 633-635
Taoka, H.; Hirano, H.; Mitsui, Y.; Umino, W.; Nobuoka, Y.; Yamashita, M.; Tanigawa, K.; Yoshimine, S.; Imai, T.; Kadowaki, S.; Miyashita, K.; Ikuma, H.; Nakamura, T.; Murata, T. 2004: Adjuvant chemotherapy for unresectable locally advanced pancreatic cancer in light of its characteristics Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(9): 1365-1370
Nakayasu, Y.; Shiozawa, S.; Usui, T.; Kuhara, K.; Kono, T.; Shimojima, Y.; Tsuchiya, A.; Miyauchi, T.; Asaka, S.; Yamaguchi, K.; Yokomizo, H.; Shimakawa, T.; Naritaka, Y. 2018: A Case of Borderline Resectable Pancreatic Head Cancer Treated by Curative Resection after Chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(13): 2306-2308
Gansauge, F.; Ramadani, M.; Schwarz, M.; Beger, H.G.; Lotspeich, E.; Poch, B. 2007: The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine and NSC-631570 in advanced pancreatic cancer Hepato-Gastroenterology 54(75): 917-920
Liu, X.; Chen, J.; Yao, W. 1999: Arterial infusion chemotherapy combined with concurrent radiotherapy for local advanced pancreatic cancer Zhonghua Zhong Liu Za Zhi 21(5): 369-370
Fujimoto, C.; Maruyama, Y.; Niina, Y.; Fujimori, N.; Sumii, T.; Funakoshi, A. 2008: A case of advanced pancreatic cancer responding to combination chemotherapy with the individual maximum repeatable dose of gemcitabine and oral S-1 Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(6): 1013-1016
Aoyama, T.; Kazama, K.; Murakawa, M.; Atsumi, Y.; Shiozawa, M.; Kobayashi, S.; Ueno, M.; Morimoto, M.; Yukawa, N.; Oshima, T.; Yoshikawa, T.; Rino, Y.; Masuda, M.; Morinaga, S. 2016: The Surgical Apgar Score Is an Independent Prognostic Factor in Patients with Pancreatic Cancer Undergoing Pancreatoduodenectomy Followed by Adjuvant Chemotherapy Anticancer Research 36(5): 2497-2503
Nishiofuku, H.; Tanaka, T.; Anai, H.; Sueyoshi, S.; Yamamoto, K.; Morimoto, K.; Maeda, S.; Masada, T.; Sho, M.; Nakajima, Y.; Tamamoto, T.; Hasegawa, M.; Sakaguchi, H.; Kichikawa, K. 2010: Locally advanced pancreatic cancer successfully treated by arterial infusion chemotherapy combined with stereotactic radiotherapy--a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(12): 2315-2318
Hoshino, H.; Takeda, Y.; Nagano, H.; Nakamori, S.; Kobayashi, S.; Eguchi, H.; Marubashi, S.; Tanemura, M.; Kitagawa, T.; Umeshita, K.; Monden, M.; Doki, Y.; Mori, M. 2009: A long-term survival case of pancreatic cancer with hepatic metastasis after pancreaticoduodenectomy successfully treated by s-1 and gemcitabine combination chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(12): 2419-2421